Lower prevalence of epsilon 4 allele of apolipoprotein E gene in healthy, longer-lived individuals of hellenic origin

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 61, Issue 12, 2006, Pages 1228-1231

  Stakias, Nikolaos ^a   Liakos, Panagiotis ^b   Tsiapali, Efthimia ^a   Goutou, Maria ^a   Koukoulis, Georgios N ^a  

^a UNIVERSITY HOSPITAL OF LARISSA   (Greece)

^b UNIVERSITY OF THESSALY   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E EPSILON 4; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; ISOPROTEIN; UNCLASSIFIED DRUG;

AGED; ALLELISM; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; ENVIRONMENTAL FACTOR; FEMALE; GENE FREQUENCY; GENOTYPE; GREECE; HEREDITY; HUMAN; HUMAN EXPERIMENT; ISCHEMIC HEART DISEASE; LONGEVITY; MALE; NORMAL HUMAN; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR;

EID: 33846414703     PISSN: 10795006     EISSN: None     Source Type: Journal    
DOI: 10.1093/gerona/61.12.1228     Document Type: Article

References (35)

1. Utermann G, Hees M, Steinmetz A. Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinemia in man. Nature. 1977;269:604.
2. Davignon J, Gregg RE, Sing CF, Apolipoprotein E polymorphism and atherosclerosis. Atherosclerosis. 1988;8:1-21.
3. Poirier J. Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease. Trends Neurosci. 1994;17:525-530.
4. Faber B, Cleutjens K, Niessen R, et al. Identification of genes potentially involved in rupture of human atherosclerotic plaques. Circ Res. 2001;89:547-554.
5. Davignon J, Cohn JS, Mabile L, et al. Apolipoprotein E and atherosclerosis: Insight from animal and human studies. Clin Chim Acta. 1999;286:115-143.
6. Utermann G, Irardewig A, Zimmer F. Apolipoprotein E phenotypes in patients with myocardial infarction. Hum Genet. 1984;65:237-241.
7. Wilson PWF, Myers RH, Larson MG, et al. Apolipoprotein E alleles, dyslipidemias and coronary heart disease: the Framingham Offspring Study. JAMA. 1994;272:1666-1671.
8. Kolovou G, Daskalova D, Mikhailidis DP. Apolipoprotein E polymorphism and atherosclerosis. Angiology. 2003;54:59-71.
9. Coudere R, Mahieux F, Bailleul S, et al. Prevalence of apolipoprotein E phenotypes in ischemic cerebrovascular disease: a case-control study. Stroke. 1993;24:661-664.
10. Ferrucci L, Guralnik JM, Pahor M, et al. Apolipoprotein E ε2 allele and risk of stroke in the older population. Stroke. 1997;28:2410-2416.
11. Song Y, Stampfer M, Liu S, Meta-analysis: apolipoprotein E genotypes and risk for coronary heart disease. Ann Intern Med. 2004;141:137-147.
12. Marin A, Medrano MJ, Gonzalez J, et al. Risk of ischaemic heart disease and acute myocardial infarction in a Spanish population: observational prospective study in a primary-care setting. BMC Public Health. 2006;6:38.
13. Kolovou G, Yiannakouris N, Hatzivassiliou M, et al. Association of apolipoprotein E polymorphism with myocardial infarction in Greek patients. Curr Med Res Opin. 2002;18:118-124.
14. Sklavounou E, Economou-Petersen E, Karadima G, et al. Apolipoprotein E polymorphism in the Greek population. Clin Genet. 1997;52:216-218.
15. Eichner JE, Terence-Dunn S, Peveen G, et al. Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review. Am J Epidemiol. 2002;155:487-495.
16. James RW, Boemi MG, Giansanti R, et al. Underexpression of the apolipoprotein E4 isoform in an Italian population. Atheroscler Throm. 1993;13:1456-1459.
17. Bailleul S, Coudere R, Landais V, et al. Direct phenotyping of human apolipoprotein E in plasma: application to population frequency distribution in Paris (France). Hum Hered. 1993;43:159-165.
18. Kolovou GD, Daskalova DCH, Hatzivassiliou M, et al. The epsilon 2 and 4 alleles of apolipoprotein E and ischemic vascular events in the Greek population -implications for the interpretation of similar studies. Angiology. 2003;54:51-58.
19. Hallman DM, Boerwinkle E, Sana N, et al. The apolipoprotein E polymorphism: a comparison of allele frequencies and effects of nine populations. Am J Hum Genet. 1991;49:338-349.
20. Stengard JH, Weiss KM, Sing CF. An ecological study of association between coronary heart disease mortality rates in men and the relative frequencies of common allelic variations in the gene coding for apolipoprotein E. Hum Genet. 1998;103:234-241.
21. Ordovas JM, Lopez MJ, Mata P. Gene-diet interaction in determining plasma lipid response to dietary intervention. Atherosclerosis. 1995;118:11-27.
22. Werle E, Fichn W, Hasslacher C, et al. Apolipoprotein E polymorphism and renal function in German type 1 and type 2 diabetic patients. Diabetes Care. 1998;21:994-998.
23. Mayeux R, Stern Y, Ottman R, et al. The apolipoprotein E4 allele in patients with Alzheimer's disease. Ann Neural. 1993;34:752-754.
24. Puttfarcken PS, Manelli AM, Falduto MT, et al. Effect of apolipoprotein E on neurite outgrown and β-amyloid-induced toxicity in developing rat primary hippocampal cultures. J Neurol. 1997;68:760-769.
25. Wilson PW, Schaefer EJ, Larson MG, et al. Apolipoprotein E alleles and risk of coronary disease. A meta-analysis. Arterioscler Thromb Vasc Biol. 1996;16:1250-1255.
26. Lahoz C, Schaefer EJ, Cupples LA, et al. Apolipoprotein E genotype and cardiovascular disease in the Framingham heart study. Atherosclerosis. 2001;154:529-537.
27. McCarron MO, Delong D, Alberts MJ. The apoE genotype as a risk factor for ischemic cerebrovascular disease: a meta-analysis in process citation. Neurology. 1999;53:1308-1311.
28. Kervinen K, Sodervik H, Makelan J, et al. Is the development of adenoma and carcinoma in proximal colon related to apolipoprotein E phenotype? Gastroenterology. 1996;110:1785-1790.
29. Zunarelli E, Nicoll JA, Migaldi M, et al. Apolipoprotein E polymorphism and breast carcinoma: correlation with cell proliferation indices and clinical outcome. Breast Cancer Res Treat. 2000;63:193-198.
30. Farrer LA, Cupples LA, Haines JL, et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Con Consortium. JAMA. 1997;278:1349-1356.
31. Bursi F, Rocca WA, Killian JM, et al. Heart disease and dementia: a population-based study. Am J Epidemiol. 2006;163:135-141.
32. Newman AB, Fitzpatrick AL, Lopez O, et al. Dementia and Alzheimer's disease incidence in relationship to cardiovascular disease in the Cardiovascular Health Study cohort. J Am Geriatr Soc. 2005;53:1101-1114.
33. Ilveskoki E, Perola M, Lehtimäki T, et al. Age-dependent association of apolipoprotein E genotype with coronary and aortic arteriosclerosis in middle-aged men: an autopsy study. Circulation. 1991;100:608-613.
34. Hallman DM, Boerwinkle E, Sana N, et al. The apolipoprotein E polymorphism: a comparison of allele frequencies and effects of nine populations. Am J Hum Genet. 1991;49:338-349.
35. Aguitar CA, Talavera G, Ordovas J, et al. The apolipoprotein E4 allele is not associated with an abnormal lipid profile in a native American population following its traditional lifestyle. Atherosclerosis. 1999;142:409-414.